ESMO 2012 News

Welcome to ESMO 2012 news. Here you will find a selection of articles that appeared in the ESMO 2012 newspaper, Congress Daily, which was distributed to attendees of the ESMO congress in Vienna.

Complete copies of the four newspapers are available for download as PDF files


Date Title Topic
30 Sep 2012 Case for including patients with brain metastases in clinical trials Head and neck cancers
30 Sep 2012 Patient rights and obligations Bioethics, legal and economic issues
30 Sep 2012 ARADES: A first-in-man study of ODM-201 Genitourinary cancers
30 Sep 2012 Analysis of NeoALTTO trial data: Too few women being offered breast-conserving treatment Breast cancer
30 Sep 2012 Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive advanced NSCLC Lung and other thoracic tumours
30 Sep 2012 EXPAND study shows no benefit from adding cetuximab to the first-line chemotherapy in advanced gastric cancer Gastrointestinal cancers
30 Sep 2012 Survey reveals ‘global pandemic’ of untreated cancer pain Personalised medicine - Palliative and supportive care
30 Sep 2012 Family cancer histories prove challenging Personalised medicine
29 Sep 2012 Clever drugs for clever cancers Gastrointestinal cancers - Anticancer agents & Biologic therapy
29 Sep 2012 Four ongoing, early stage trials evaluate novel agents in NSCLC patients with ALK-positive and EGFR mutated tumours Lung and other thoracic tumours
29 Sep 2012 COG study: Addressing the need for second-line treatments in oesophageal cancer Head and neck cancers
29 Sep 2012 Combining S-1 and docetaxel improves survival in advanced gastric cancer Gastrointestinal cancers
29 Sep 2012 Young Oncologists: Master Class in Trial Design Basic science
29 Sep 2012 New ‘first-in-man’ data to be presented at ESMO Basic science
29 Sep 2012 Phase III MISSION trial of sorafenib monotherapy in heavily pretreated patients with non-small cell lung cancer Lung and other thoracic tumours